Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide

Resistance to chemotherapy is a common phenomenon in malignant melanoma. In order to assess the role of altered DNA repair in chemoresistant melanoma, we investigated different DNA repair pathways in one parental human melanoma line (MeWo) and in sublines of MeWo selected <i>in vitro</i>...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rünger, Thomas M. (VerfasserIn) , Schadendorf, Dirk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2000
In: The journal of investigative dermatology
Year: 2000, Jahrgang: 114, Heft: 1, Pages: 34-39
ISSN:1523-1747
DOI:10.1046/j.1523-1747.2000.00844.x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1046/j.1523-1747.2000.00844.x
Verlag, Volltext: https://www.jidonline.org/article/S0022-202X(15)40727-4/abstract
Volltext
Verfasserangaben:Thomas M. Rünger, Steffen Emmert, Dirk Schadendorf, Caroline Diem, Bernd Epe, and Doris Hellfritsch

MARC

LEADER 00000caa a2200000 c 4500
001 1587883341
003 DE-627
005 20220815111139.0
007 cr uuu---uuuuu
008 190221s2000 xx |||||o 00| ||eng c
024 7 |a 10.1046/j.1523-1747.2000.00844.x  |2 doi 
035 |a (DE-627)1587883341 
035 |a (DE-576)517883341 
035 |a (DE-599)BSZ517883341 
035 |a (OCoLC)1341039913 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rünger, Thomas M.  |d 1959-  |e VerfasserIn  |0 (DE-588)1081960515  |0 (DE-627)846923041  |0 (DE-576)454989024  |4 aut 
245 1 0 |a Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide  |c Thomas M. Rünger, Steffen Emmert, Dirk Schadendorf, Caroline Diem, Bernd Epe, and Doris Hellfritsch 
264 1 |c 2000 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.02.2019 
520 |a Resistance to chemotherapy is a common phenomenon in malignant melanoma. In order to assess the role of altered DNA repair in chemoresistant melanoma, we investigated different DNA repair pathways in one parental human melanoma line (MeWo) and in sublines of MeWo selected <i>in vitro</i> for drug resistance against four commonly used drugs (cisplatin, fotemustine, etoposide, and vindesine). Host cell reactivation assays with the plasmid pRSVcat were used to assess processing of different DNA lesions. With ultraviolet-irradiated plasmids, no significant differences were found, indicating a normal (nucleotide excision) repair of DNA photoproducts. With singlet oxygen-treated plasmid, the fotemustine- and cisplatin-resistant lines exhibited a significantly increased (base excision) repair of oxidative DNA damage. With fotemustine-treated plasmid, the fotemustine-resistant subline did not exhibit an increased repair of directly fotemustine-induced DNA damage. Similar results were obtained with cisplatin-induced DNA crosslinks in the cisplatin-resistant line. The fotemustine- and etoposide-resistant sublines have been shown to exhibit a reduced expression of genes involved in DNA mismatch repair. We used a ‘‘host cell microsatellite stability assay'' with the plasmid pZCA29 and found a 2.0-fold to 2.5-fold increase of microsatellite frameshift mutations (p ≤0.002) in the two resistant sublines. This indicates microsatellite instability, the hallmark of an impaired DNA mismatch repair. The increased repair of oxidative DNA damage might mediate an increased chemoresistance through an improved repair of drug-induced DNA damage. In contrast, a reduced DNA mismatch repair might confer resistance by preventing futile degradation of newly synthesized DNA opposite alkylation damage, or by an inability to detect such damage and subsequent inability to undergo DNA-damage-induced apoptosis. 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
773 0 8 |i Enthalten in  |t The journal of investigative dermatology  |d Amsterdam : Elsevier, 1938  |g 114(2000), 1, Seite 34-39  |h Online-Ressource  |w (DE-627)320457990  |w (DE-600)2006902-9  |w (DE-576)09114289X  |x 1523-1747  |7 nnas  |a Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide 
773 1 8 |g volume:114  |g year:2000  |g number:1  |g pages:34-39  |g extent:6  |a Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide 
856 4 0 |u http://dx.doi.org/10.1046/j.1523-1747.2000.00844.x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.jidonline.org/article/S0022-202X(15)40727-4/abstract  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190221 
993 |a Article 
994 |a 2000 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 3 
999 |a KXP-PPN1587883341  |e 3056336538 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1587883341","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 21.02.2019"],"title":[{"title_sort":"Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide","title":"Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide"}],"person":[{"family":"Rünger","given":"Thomas M.","display":"Rünger, Thomas M.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Schadendorf, Dirk","roleDisplay":"VerfasserIn","role":"aut","family":"Schadendorf","given":"Dirk"}],"relHost":[{"origin":[{"publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","dateIssuedKey":"1938","dateIssuedDisp":"1938-","publisherPlace":"Amsterdam ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke [u.a.]"}],"id":{"issn":["1523-1747"],"eki":["320457990"],"zdb":["2006902-9"]},"name":{"displayForm":["Society for Investigative Dermatology ; European Society for Dermatological Research"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"journal of investigative dermatology","title":"The journal of investigative dermatology"}],"pubHistory":["1.1938 -"],"titleAlt":[{"title":"an international journal for research in cutaneous biology"}],"part":{"extent":"6","text":"114(2000), 1, Seite 34-39","volume":"114","pages":"34-39","issue":"1","year":"2000"},"disp":"Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposideThe journal of investigative dermatology","note":["Gesehen am 16.02.16"],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"Society for Investigative Dermatology","role":"isb"}],"language":["eng"],"recId":"320457990"}],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1587883341"],"doi":["10.1046/j.1523-1747.2000.00844.x"]},"origin":[{"dateIssuedDisp":"2000","dateIssuedKey":"2000"}],"name":{"displayForm":["Thomas M. Rünger, Steffen Emmert, Dirk Schadendorf, Caroline Diem, Bernd Epe, and Doris Hellfritsch"]}} 
SRT |a RUENGERTHOALTERATION2000